KENYON LAWRENCE A 4
4 · Outlook Therapeutics, Inc. · Filed Sep 30, 2024
Insider Transaction Report
Form 4
KENYON LAWRENCE A
CFO and Secretary
Transactions
- Purchase
Common Stock
2024-09-26$5.69/sh+5,000$28,446→ 5,946 total
Footnotes (1)
- [F1]Reflects the Issuer's 1-for-20 reverse stock split effected on March 13, 2024.